DekaBank Deutsche Girozentrale - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$1,422,000
+11.6%
12,7300.0%0.01%
-8.3%
Q1 2017$1,274,000
-15.7%
12,730
-7.9%
0.01%
-25.0%
Q4 2016$1,511,000
-4.4%
13,820
+8.1%
0.02%
-11.1%
Q3 2016$1,581,000
+17.0%
12,7800.0%0.02%
+20.0%
Q2 2016$1,351,000
+3.6%
12,780
+11.9%
0.02%0.0%
Q1 2016$1,304,00011,4200.02%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Ariose Capital Management Ltd 88,655$10,149,0009.57%
WARBURG PINCUS LLC 4,087,200$467,903,0008.91%
RUDMAN ERROL M 64,001$7,327,0004.96%
INDUS CAPITAL PARTNERS, LLC 378,518$43,333,0004.22%
OBERWEIS ASSET MANAGEMENT INC/ 90,105$10,315,0002.98%
Ativo Capital Management LLC 85,623$9,802,0002.66%
Sensato Investors LLC 113,296$12,970,0002.31%
Cormorant Asset Management, LP 111,500$12,765,0001.92%
BARING ASSET MANAGEMENT Ltd 128,784$14,743,0001.23%
Visium Asset Management, LP 484,619$55,479,0000.94%
View complete list of CHINA BIOLOGIC PRODS INC shareholders